News
- Author:
- Will Pass
Publish date: March 25, 2019
Review of 54 papers for gabapentin and 30 for pregabalin finds little evidence for effective pain control in off-label uses.
News
- Author:
- Will Pass
Publish date: March 22, 2019
The triplet combination of rituximab plus combination high-dose methotrexate and temozolomide could be a safe and effective first-line option for p...
News
- Author:
- Will Pass
Publish date: March 20, 2019
During model development, the hazard ratio for decompensation was 7.10 among patients with high risk scores.
News
- Author:
- Will Pass
Publish date: March 20, 2019
There was a survival gap between black and white patients, even though black patients with mantle cell lymphoma were more likely to be treated in a...
Article
- Author:
- Will Pass
Publish date: March 18, 2019
Survival rates remained largely unchanged from 2000-2014 for infants who underwent allogeneic hematopoietic cell transplan...
News
- Author:
- Will Pass
Publish date: March 17, 2019
The health status findings further support the device as a valuable treatment option for heart failure patients with severe secondary mitral regurg...
News
- Author:
- Will Pass
Publish date: March 14, 2019
Women who have survived epithelial ovarian cancer (EOC) more often report severe long-term fatigue than healthy women, according to a case-control ...
News
- Author:
- Will Pass
Publish date: March 13, 2019
An extension of the pathfinder 2 trial produced encouraging results with providing a stepped-down regimen in severe hemophilia A patients.
News
- Author:
- Will Pass
Publish date: March 13, 2019
A survey of men with hemophilia reveals that erectile dysfunction may be fairly common with the bleeding disorder and that its prevalence increases...
News
- Author:
- Will Pass
Publish date: March 12, 2019
On the heels of increased reports of breast implant–related anaplastic large cell lymphoma, researchers report a case of lymphoma that may be linke...
News
- Author:
- Will Pass
Publish date: March 12, 2019
A Cochrane review found weak evidence to support limited use of mesenchymal stem cells in hematopoietic transplant.
News
- Author:
- Will Pass
Publish date: March 7, 2019
The results of the study in rats could explain striking phenotype-genotype discrepancies between patients with Wilson disease, and may give reason ...
News
- Author:
- Will Pass
Publish date: March 6, 2019
Women more often had infections and comorbidities, while men more often had liver decompensation, which contributed most significantly to their hig...
News
- Author:
- Will Pass
Publish date: March 4, 2019
Although approximately 2% of cancer cases at Memorial Sloan Kettering Cancer Center are pediatric, 34.1% of single-patient uses of investigational ...
News
- Author:
- Will Pass
Publish date: March 1, 2019
PRAGUE – The biggest question for gene therapy today is durability, according to Dr. John Pasi.
